Patents expiring in 2034

US 8624032

Compound libraries made through phosphine-catalyzed annulation/Tebbe/Diels-Alder reactions

The Regents of the University of California · Granted Tue Jan 07 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 02 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8623405

Finely divided composition containing poorly water soluble substance

Takeda Pharmaceutical Company Limited · Granted Tue Jan 07 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 02 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8623397

Delivery device and method for forming the same

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Jan 07 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 02 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8623915

Cycloalkyl-hydroxyl compounds and compositions for cholesterol management and related uses

Esperion Therapeutics, Inc. · Granted Tue Jan 07 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 02 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8623867

Cyclic amine BACE-1 inhibitors having a benzamide substituent

Pharmacopeia Drug Discovery, Inc. · Granted Tue Jan 07 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 02 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8623814

Antiviral agents

Enanta Pharmaceuticals, Inc. · Granted Tue Jan 07 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 02 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8623383

Recombinant antigens for diagnosis and prevention of spotted fever rickettsiae

United States of America as represented by the Secretary of the Air Force · Granted Tue Jan 07 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 02 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8622920

Breath test device and method

EXALENZ BIOSCIENCE LTD. · Granted Tue Jan 07 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 02 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8623869

Compounds useful as inhibitors of ATR kinase

Vertex Pharmaceuticals Incorporated · Granted Tue Jan 07 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 02 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8623917

Uses of prostacyclin analogs

The Regents of the University of Colorado, a Body Corporate · Granted Tue Jan 07 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 02 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8623828

Blocking mesothelin peptide fragments

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Jan 07 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 02 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8623371

Targeting poly-gama-glutamic acid to treat Staphylococcus epidermidis and related infections

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Jan 07 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 02 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8623847

Compositions for treatment of inflammatory diseases

The Regents of the University of Oklahoma · Granted Tue Jan 07 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 02 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8623614

Method for the recombinant production of magnetic nanoparticles

Ludwig-Maximilians-Universitat Munchen · Granted Tue Jan 07 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 02 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8623894

Solid forms of N-[2,4-Bis(1,1-dimethyethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquioline-3-carboxamide

Vertex Pharmaceuticals Incorporated · Granted Tue Jan 07 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 02 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8623905

Modulators of ATP-binding cassette transporters

Vertex Pharmaceuticals Incorporated · Granted Tue Jan 07 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 02 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8623841

Medical and nutritional applications of highly refined cellulose

Regents of the University of Minnesota · Granted Tue Jan 07 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 02 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8623330

Emollient foams for treatment of seborrheic dermatitis

Precision Dermatology, Inc. · Granted Tue Jan 07 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 02 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8623832

Peptide compositions that bind TLR-4

The Board of Regents of the University of Oklahoma · Granted Tue Jan 07 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 02 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

EP 2682113

Verschließen wirkstoffhaltiger Laminate

ACINO AG [DE] · Granted Wed Jan 08 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Tue Jan 03 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8629177

Nanoencapsulated delta-9-tetrahydrocannabinol

Aphios Corporation · Granted Tue Jan 14 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 09 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8629162

Modulators of ATP-binding cassette transporters

Vertex Pharmaceuticals Incorporated · Granted Tue Jan 14 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 09 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8629156

Tryptophan hydroxylase inhibitors

LEXICON PHARMACEUTICALS, INC. · Granted Tue Jan 14 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 09 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8629141

Spiro-oxindole MDM2 antagonists

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Jan 14 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 09 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8629119

Dual targeting of MIR-208 and MIR-499 in the treatment of cardiac disorders

The Board of Regents of the University of Texas System · Granted Tue Jan 14 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 09 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8628917

Genes of an otitis media isolate of nontypeable Haemophilus influenzae

The Board of Regents of the University of Oklahoma · Granted Tue Jan 14 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 09 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8628780

Lutzomyia longipalpis polypeptides and methods of use

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Jan 14 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 09 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8628962

Differentiation of stem cells into dopaminergic cells

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jan 14 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 09 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8628764

Biocontrol of storage maladies of potatoes by bacterial antagonists produced in co-culture

The United States of America, as represented by the Secretary of Agriculture · Granted Tue Jan 14 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 09 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8629127

Compositions and methods of treatment for inflammatory diseases

The Regents of the University of Oklahoma · Granted Tue Jan 14 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 09 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8628782

Deletion of the beta 20-21 loop in HIV gp120 exposes the CD4 binding site for improved antibody binding and antibody induction

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jan 14 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 09 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8629260

Anti-arthropod vector vaccines, methods of selecting and uses thereof

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Jan 14 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 09 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8628769

Modified vitamin K-dependent polypeptides

Regents of the University of Minnesota · Granted Tue Jan 14 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 09 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8632782

Recombinant attenuated dengue viruses comprising mutations in NS5 and the 3′ untranslated region

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jan 21 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 16 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8632751

Scanning suspension comprising a particle with a diameter of at least 1 micrometer

Universitair Medisch Centrum Utrecht · Granted Tue Jan 21 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 16 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8632771

High molecular weight derivatives of vitamin K-dependent polypeptides

The United States of America as represented by Department of Veterens Affairs · Granted Tue Jan 21 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 16 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8632510

Nanochanneled device and related methods

The Board of Regents of the University of Texas System · Granted Tue Jan 21 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 16 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8633154

Cyclodepsipeptides with antineoplastic activity and methods of using to inhibit cancer and microbial growth

ARIZONA BOARD OF REGENTS, A BODY CORPORATE OF THE STATE OF ARIZONA ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Tue Jan 21 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 16 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8633034

Methods for evaluating the aggregation of a protein in a suspension including organopolysiloxane and medical articles coated with organopolysiloxane containing a protein solution

The Regents of the University of Colorado · Granted Tue Jan 21 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 16 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8633277

Methods for forming polymer-drug conjugates

Nektar Therapeutics · Granted Tue Jan 21 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 16 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8633210

Triazole compounds useful as protein kinase inhibitors

Vertex Pharmaceuticals Incorporated · Granted Tue Jan 21 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 16 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8633177

Nitroxyl (HNO) releasing compounds and uses thereof in treating diseases

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jan 21 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 16 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8633189

Modulators of cystic fibrosis transmembrane conductance regulator

Vertex Pharmaceuticals Incorporated · Granted Tue Jan 21 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 16 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8632808

Taste-masking solid preparation of pioglitazone

Takeda Pharmaceutical Company Limited · Granted Tue Jan 21 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 16 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8633120

Lyocell fiber

LENZING AKTIENGESELLSCHAFT · Granted Tue Jan 21 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 16 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8633019

Methods for treating spinal muscular atrophy

PTC THERAPEUTICS, INC. · Granted Tue Jan 21 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 16 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8632839

Methods of forming self-supporting films for delivery of therapeutic agents

Covidien LP · Granted Tue Jan 21 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 16 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8633178

Natural combination hormone replacement formulations and therapies

Compass Therapeutics LLC · Granted Tue Jan 21 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 16 2034 00:00:00 GMT+0000 (Coordinated Universal Time)